Logo

Nanoligent SL

Company
1

followers

Primary tabs

About your organization / profile

Nanoligent is a preclinical stage drug discovery company based in Barcelona with very successful preclinical data and a robust IP portfolio. The company is focused on METASTASIS as an unmet clinical need, developing precision medicines that selectively target metastatic stem cells. Currently focused on metastatic colorectal cancer, a huge market, as a first entry indication, with our technology allowing further application in 22 other cancer types. The therapeutic approach is the selective elimination of CXCR4 positive stem cells in cancer tissues. CXCR4 is a well-known therapeutic target, not yet explored for colorectal cancer, but highly correlated with poor prognosis.

Network (0)

There are no organizations in the network.